Furthermore, the results provide the first in vivo evidence that GRA may exert its curative effects on experimental visceral leishmaniasis mostly through its ability to activate NF-κB by inducing phosphorylation and subsequent degradation of IκBα. Here, NFKB1 is linked to visceral leishmaniasis.